Pharmacological small molecules for the treatment of lysosomal storage disorders

Author： Smid BE   Aerts JMFG   Boot RG   Linthorst GE   Hollak CEM  

Publisher： Informa Healthcare

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.19, Iss.11, 2010-11, pp. : 1367-1379

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Treatment options for lysosomal storage disorders: developing insights

By van Gelder Carin M   Vollebregt Audrey AM   Plug Iris   van der Ploeg Ans T   Reuser Arnold JJ  

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 16, 2012-11 ,pp. : 2281-2299

Informa Healthcare

Access to resources Recommend Favorite

Treatment of Lysosomal Storage Disorders: Progress with Enzyme Replacement Therapy

By Rohrbach Marianne   Clarke Joe T.R.  

Drugs, Vol. 67, Iss. 18, 2007-01 ,pp. : 2697-2716

Adis International

Access to resources Recommend Favorite

A contradictory treatment for lysosomal storage disorders: inhibitors enhance mutant enzyme activity

By Fan J.-Q.  

Trends in Pharmacological Sciences, Vol. 24, Iss. 7, 2003-07 ,pp. : 355-360

Elsevier

Access to resources Recommend Favorite

Treatment perspectives for the lysosomal storage diseases

By Grabowski Gregory A  

Expert Opinion on Emerging Drugs, Vol. 13, Iss. 1, 2008-03 ,pp. : 197-211

Informa Healthcare

Access to resources Recommend Favorite

Current and emerging therapies for the lysosomal storage disorders

By Pastores Gregory M   Barnett Natalie L  

Expert Opinion on Emerging Drugs, Vol. 10, Iss. 4, 2005-11 ,pp. : 891-902

Informa Healthcare

Access to resources Recommend Favorite